ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

Coalition Members Urged To Demand Intent Of Congress In Cancer Act Be Recognized

March 13, 1981

In Brief: Chamberlain, Kupchella Lead Educators; Mattel Donates $25 Million To UCLA Children’s

November 20, 1998

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997